Lymphocyte-to-CRP ratio and coronary artery disease
Part of Heart & circulation clinical trials.
This study looks at whether a simple blood test, the ratio of lymphocytes to C-reactive protein, can help doctors understand how complex a person's coronary artery disease is. It might help predict the severity of heart disease and guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a heart attack and received a stent within 12 hours of symptoms, or you are having a planned stent procedure for known coronary artery disease.
- You have not had a previous heart attack, stent, or heart bypass surgery.
- You do not have autoimmune or chronic inflammatory diseases, active infections, cancer, or severe kidney or liver problems.
- You are not on medications that suppress your immune system.
- You have not been diagnosed with leukemia in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of coronary artery disease: one linked to inflammation (IR-CAD) and the standard type (AS-CAD). If you have had a heart procedure and were recently hospitalized for worsening chest pain, this study may help doctors understand your condition better.
This study follows people who have both coronary artery disease (narrowed heart arteries) and signs of chronic inflammation to learn more about their condition, current treatments, and outcomes. It helps doctors understand how best to care for patients like you.
This study looks at whether a comprehensive add-on treatment—starting with immune medicine and then a heart procedure when needed—can improve outcomes for people whose coronary artery disease is getting worse quickly. It focuses on cases where inflammation is likely driving new artery blockages or worsening chest pain.
This trial studies a new way to check for coronary artery disease (blocked heart arteries) in people with chest pain or other symptoms that might be caused by it. The goal is to see if this method is accurate and helpful for diagnosing the condition.
This trial compares a personalized evaluation approach to standard care for people with new chest pain who might have heart disease. It aims to see if tailoring tests can improve diagnosis and outcomes.
This trial focuses on people with stable coronary artery disease who are scheduled for planned angioplasty (PCI). It looks for a “precision medicine” approach to identify who may be at risk for a small heart injury around the procedure, so doctors can better prevent it.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.